Login Preferences
About News Publications Statistics Downloads API Guide License How to use Preferences
bn:03479149n
Noun Concept
Categories: World Health Organization essential medicines, Monoclonal antibodies, Belgian inventions, Biotechnology, Disease-modifying antirheumatic drugs
EN
certolizumab pegol  ATC code L04AB05  ATCvet code QL04AB05  CDP-870  CDP870
EN
Certolizumab pegol, sold under the brand name Cimzia, is a biopharmaceutical medication for the treatment of Crohn's disease, rheumatoid arthritis, psoriatic arthritis and ankylosing spondylitis. Wikipedia
Definitions
Relations
Sources
EN
Certolizumab pegol, sold under the brand name Cimzia, is a biopharmaceutical medication for the treatment of Crohn's disease, rheumatoid arthritis, psoriatic arthritis and ankylosing spondylitis. Wikipedia
Pharmaceutical drug Wikidata
IS A
compound
medicine
biopharmaceutical
MEDICAL CONDITION TREATED
ankylosing spondylitis
arthritis
spondylitis
ulcerative colitis
polyarthritis
Wikipedia
EN
certolizumab pegol
Wikidata
EN
Certolizumab pegol
Wikipedia Redirections
EN
ATC code L04AB05, ATCvet code QL04AB05, certolizumab, Cimzia, Pegol, certolizumab
Wikidata Alias
EN
CDP-870, CDP870, PHA-738144

Please note that, in order to improve your browsing experience on this website, BabelNet® uses various types of cookies, including: browsing functionality, performance and statistical cookies.

By continuing to browse the site you are agreeing to our use of cookies. OK

License